Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation

J Perinatol. 2009 Nov;29(11):731-7. doi: 10.1038/jp.2009.85. Epub 2009 Jul 9.

Abstract

Objective: To determine whether prenatal treatment with a single course of glucocorticoids (GCs) affects size at birth among full-term infants independent of fetal size before GC administration or exposure to preterm labor (PTL).

Study design: In all, 105 full-term infants were recruited into three study groups (30 GC treated; 60 controls matched for gestational age (GA) at birth and sex; and 15 PTL controls without GC exposure). Size of the infants was estimated before treatment using two-dimensional (2D) ultrasound and by direct measurement at birth.

Results: Length, weight and head circumference at birth were smaller among GC-treated infants compared with matched controls (P's<0.01), although fetal size did not differ before treatment (P's>0.2). Exposure to PTL did not account for this effect.

Conclusions: Prenatal treatment with a single course of GCs was associated with a reduction in size at birth among infants born at term gestation. This effect cannot be explained by differences in fetal size before treatment or exposure to PTL.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / administration & dosage
  • Anti-Inflammatory Agents / adverse effects*
  • Betamethasone / administration & dosage
  • Betamethasone / adverse effects*
  • Birth Weight / drug effects*
  • Female
  • Fetal Development / drug effects
  • Humans
  • Infant, Newborn
  • Male
  • Obstetric Labor, Premature / drug therapy
  • Pregnancy
  • Respiratory Distress Syndrome, Newborn / prevention & control*
  • Ultrasonography, Prenatal

Substances

  • Anti-Inflammatory Agents
  • Betamethasone